Eye On Five

OIS - Eye on Five

Eye on Five – August Edition

By Tom Salemi | September 1, 2016

Shire Makes Xiidra Available in US With FDA approval of Xiidra (liftegrast) in hand, its dry eye challenger to Allergan’s Restasis (cyclosporine), the next step…

Read More
OIS - Eye on Five

Eye on Five – July Edition

By Tom Salemi | August 2, 2016

CyPass Micro-Stent Gets FDA Thumbs Up The FDA topped off a busy month of ophthalmic approvals last week with its blessing of the CyPass Micro-Stent…

Read More
OIS - Eye on Five

Eye on Five – June Edition

By Rich Kirkner | July 1, 2016

After Trial Fails, Acucela Goes It Alone with Emixustat Otsuka Pharmaceutical Group terminated its agreement with Acucela to develop emixustat after the Phase IIB/III trial…

Read More
OIS - Eye on Five

Eye on Five – May Edition

By Tom Salemi | June 3, 2016

Burden of Eye Problems to Double By 2050 Researchers at the University of Southern California (USC) Roski Eye Institute reported in JAMA Ophthalmology that the…

Read More
OIS - Eye on Five

Eye on Five – April Edition

By Tom Salemi | April 27, 2016

FDA Approves Avedro Corneal Collagen Cross-linking Platform The US Food and Drug Administration finally gave a green light to Avedro Inc. for its KXL System,…

Read More
OIS - Eye on Five

Eye on Five – March Edition

By Rich Kirkner | March 31, 2016

Regeneron, Bayer Join to Develop Combined Therapy Regeneron Pharmaceuticals and Bayer announced an agreement to jointly develop a combination therapy of the angiopoietin2 (Ang2) antibody…

Read More
OIS - Eye on Five

Eye on Five – February Edition

By Rich Kirkner | February 29, 2016

The Transcend acquisition tops the list, but February was a promising month for ophthalmology. Alcon Leaps into MIGS with Transcend With its acquisition of Transcend…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.